Carlsmed, Inc., a commercial-stage company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California. Show more

Location: 1800 Aston Avenue, Carlsbad, CA, 92008, United States | Website: https://carlsmed.com | Industry: Health Information Services | Sector: Healthcare


Market Cap

379.5M

52 Wk Range

$11.45 - $17.19

Previous Close

$14.27

Open

$14.36

Volume

10,256

Day Range

$13.51 - $14.39

Enterprise Value

281.7M

Cash

115.4M

Avg Qtr Burn

-6.965M

Insider Ownership

42.83%

Institutional Own.

38.81%

Qtr Updated

09/30/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date